Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP580637.RACIxj0GkHwDkGWE2ZolC36WOIpDClnH7oN-ZT_wJWx60130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP580637.RACIxj0GkHwDkGWE2ZolC36WOIpDClnH7oN-ZT_wJWx60130_assertion type Assertion NP580637.RACIxj0GkHwDkGWE2ZolC36WOIpDClnH7oN-ZT_wJWx60130_head.
- NP580637.RACIxj0GkHwDkGWE2ZolC36WOIpDClnH7oN-ZT_wJWx60130_assertion description "[We used a recombinant adenovirus that carries a lethal gene [p53-up-regulated modulator of apoptosis (PUMA)] under the control of a beta-catenin/Tcf-responsive promoter (AdTOP-PUMA) to selectively target human colorectal cancer cells (SW480, HCT116, DLD-1, and LS174T), hepatocellular carcinoma (HepG2), and gastric cancer cells (AGS) in which the beta-catenin/Tcf pathway is activated, and compared its efficiency in killing cancer cells in which this pathway is inactive or only weakly active.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP580637.RACIxj0GkHwDkGWE2ZolC36WOIpDClnH7oN-ZT_wJWx60130_provenance.
- NP580637.RACIxj0GkHwDkGWE2ZolC36WOIpDClnH7oN-ZT_wJWx60130_assertion evidence source_evidence_literature NP580637.RACIxj0GkHwDkGWE2ZolC36WOIpDClnH7oN-ZT_wJWx60130_provenance.
- NP580637.RACIxj0GkHwDkGWE2ZolC36WOIpDClnH7oN-ZT_wJWx60130_assertion SIO_000772 17121933 NP580637.RACIxj0GkHwDkGWE2ZolC36WOIpDClnH7oN-ZT_wJWx60130_provenance.
- NP580637.RACIxj0GkHwDkGWE2ZolC36WOIpDClnH7oN-ZT_wJWx60130_assertion wasDerivedFrom befree-2016 NP580637.RACIxj0GkHwDkGWE2ZolC36WOIpDClnH7oN-ZT_wJWx60130_provenance.
- NP580637.RACIxj0GkHwDkGWE2ZolC36WOIpDClnH7oN-ZT_wJWx60130_assertion wasGeneratedBy ECO_0000203 NP580637.RACIxj0GkHwDkGWE2ZolC36WOIpDClnH7oN-ZT_wJWx60130_provenance.